After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia

An emerging body of evidence demonstrates that defects in antileukemic effector cells in patients with acute myeloid leukemia (AML) can contribute to the development and/or persistence of the disease. In particular, immune suppressive regulatory T cells (Tregs) may contribute to this defective antil...

Descripción completa

Detalles Bibliográficos
Autores principales: Delia, Mario, Carluccio, Paola, Mestice, Anna, Frappampina, Roberta, Albano, Francesco, Specchia, Giorgina, Musto, Pellegrino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657695/
https://www.ncbi.nlm.nih.gov/pubmed/33204734
http://dx.doi.org/10.1155/2020/2134647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657695/
https://www.ncbi.nlm.nih.gov/pubmed/33204734
http://dx.doi.org/10.1155/2020/2134647

Ejemplares similares